First Time Loading...

Neovasc Inc
TSX:NVCN

Watchlist Manager
Neovasc Inc Logo
Neovasc Inc
TSX:NVCN
Watchlist
Price: 40.15 CAD Market Closed
Updated: May 15, 2024

Intrinsic Value

NVCN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. [ Read More ]

The intrinsic value of one NVCN stock under the Base Case scenario is 7.37 CAD. Compared to the current market price of 40.15 CAD, Neovasc Inc is Overvalued by 82%.

Key Points:
NVCN Intrinsic Value
Base Case
7.37 CAD
Overvaluation 82%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Neovasc Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NVCN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Neovasc Inc

Provide an overview of the primary business activities
of Neovasc Inc.

What unique competitive advantages
does Neovasc Inc hold over its rivals?

What risks and challenges
does Neovasc Inc face in the near future?

Summarize the latest earnings call
of Neovasc Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Neovasc Inc.

Provide P/S
for Neovasc Inc.

Provide P/E
for Neovasc Inc.

Provide P/OCF
for Neovasc Inc.

Provide P/FCFE
for Neovasc Inc.

Provide P/B
for Neovasc Inc.

Provide EV/S
for Neovasc Inc.

Provide EV/GP
for Neovasc Inc.

Provide EV/EBITDA
for Neovasc Inc.

Provide EV/EBIT
for Neovasc Inc.

Provide EV/OCF
for Neovasc Inc.

Provide EV/FCFF
for Neovasc Inc.

Provide EV/IC
for Neovasc Inc.

Show me price targets
for Neovasc Inc made by professional analysts.

What are the Revenue projections
for Neovasc Inc?

How accurate were the past Revenue estimates
for Neovasc Inc?

What are the Net Income projections
for Neovasc Inc?

How accurate were the past Net Income estimates
for Neovasc Inc?

What are the EPS projections
for Neovasc Inc?

How accurate were the past EPS estimates
for Neovasc Inc?

What are the EBIT projections
for Neovasc Inc?

How accurate were the past EBIT estimates
for Neovasc Inc?

Compare the revenue forecasts
for Neovasc Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Neovasc Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Neovasc Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Neovasc Inc compared to its peers.

Compare the P/E ratios
of Neovasc Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Neovasc Inc with its peers.

Analyze the financial leverage
of Neovasc Inc compared to its main competitors.

Show all profitability ratios
for Neovasc Inc.

Provide ROE
for Neovasc Inc.

Provide ROA
for Neovasc Inc.

Provide ROIC
for Neovasc Inc.

Provide ROCE
for Neovasc Inc.

Provide Gross Margin
for Neovasc Inc.

Provide Operating Margin
for Neovasc Inc.

Provide Net Margin
for Neovasc Inc.

Provide FCF Margin
for Neovasc Inc.

Show all solvency ratios
for Neovasc Inc.

Provide D/E Ratio
for Neovasc Inc.

Provide D/A Ratio
for Neovasc Inc.

Provide Interest Coverage Ratio
for Neovasc Inc.

Provide Altman Z-Score Ratio
for Neovasc Inc.

Provide Quick Ratio
for Neovasc Inc.

Provide Current Ratio
for Neovasc Inc.

Provide Cash Ratio
for Neovasc Inc.

What is the historical Revenue growth
over the last 5 years for Neovasc Inc?

What is the historical Net Income growth
over the last 5 years for Neovasc Inc?

What is the current Free Cash Flow
of Neovasc Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Neovasc Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Neovasc Inc

Current Assets 29.8m
Cash & Short-Term Investments 25.8m
Receivables 2.5m
Other Current Assets 1.5m
Non-Current Assets 8.9m
PP&E 502.9k
Other Non-Current Assets 8.4m
Current Liabilities 10.1m
Accounts Payable 2.2m
Accrued Liabilities 2.6m
Other Current Liabilities 5.3m
Non-Current Liabilities 12.8m
Long-Term Debt 12.8m
Other Non-Current Liabilities 43.6k
Efficiency

Earnings Waterfall
Neovasc Inc

Revenue
3.8m USD
Cost of Revenue
-773.8k USD
Gross Profit
3m USD
Operating Expenses
-36.2m USD
Operating Income
-33.2m USD
Other Expenses
-8m USD
Net Income
-41.2m USD

Free Cash Flow Analysis
Neovasc Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NVCN Profitability Score
Profitability Due Diligence

Neovasc Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
ROIC is Increasing
Exceptional 1-Year Revenue Growth
39/100
Profitability
Score

Neovasc Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

NVCN Solvency Score
Solvency Due Diligence

Neovasc Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Low D/E
39/100
Solvency
Score

Neovasc Inc's solvency score is 39/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NVCN Price Targets Summary
Neovasc Inc

There are no price targets for NVCN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

NVCN Price
Neovasc Inc

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
+75%
5Y 5Y
-76%
10Y 10Y
-100%
Annual Price Range
40.15
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return -49.07%
Standard Deviation of Annual Returns 26.42%
Max Drawdown -97%
Shares Statistics
Market Capitalization 110.5m CAD
Shares Outstanding 2 759 220
Percentage of Shares Shorted 0.05%

NVCN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Neovasc Inc Logo
Neovasc Inc

Country

Canada

Industry

Health Care

Market Cap

110.5m CAD

Dividend Yield

0%

Description

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures and markets products for the cardiovascular marketplace. The firm's products include the Neovasc ReducerTM (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle and the TiaraTM (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.

Contact

BRITISH COLUMBIA
Richmond British Columbia
Richmond, 5138-13562 Maycrest Way
+16042704344.0
https://www.neovasc.com/

IPO

2001-05-23

Employees

71

Officers

Pres, CEO & Director
Mr. Fredericus A. Colen
CFO & Corp. Sec.
Mr. Christopher Clark B.A., BA (Honours), C.A., CA, PgD
Chief Operating Officer
Mr. William Reed Little
Chief Quality Officer
Mr. John Christopher Panton
VP of Clinical Affairs
Sarah Marie-Hodgson Gallagher

See Also

Discover More
What is the Intrinsic Value of one NVCN stock?

The intrinsic value of one NVCN stock under the Base Case scenario is 7.37 CAD.

Is NVCN stock undervalued or overvalued?

Compared to the current market price of 40.15 CAD, Neovasc Inc is Overvalued by 82%.